Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

CONTEXT: Prostate cancer (PCa) patients have many options within the realms of surgery
or radiation therapy (RT). Technical advancements in RT planning and delivery have …

PURPOSE: To provide updated American Brachytherapy Society (ABS) guidelines for
transrectal ultrasound-guided transperineal interstitial permanent prostate brachytherapy …

Erectile dysfunction (ED) is a common sequela after external beam radiotherapy and
brachytherapy for prostate cancer. There are several structures in the vicinity of the prostate …

Treatment selection for men undergoing curative treatment for prostate cancer is often a
challenging decision in view of the goal of maximising cure while maintaining quality of life …

Over the past two decades, brachytherapy has played an ever expanding role in the
definitive radiotherapy of prostate cancer. Brachytherapy surpasses external beam …

OBJECTIVES: To report the genitourinary (GU) and gastrointestinal (GI) toxicity rates,
erectile function preservation, and biochemical outcome (bNED) in men aged≤ 55 years …

PURPOSE: To analyze the correlation between dose-volume parameters of the corpora
cavernosa and erectile dysfunction (ED) after external beam radiotherapy (EBRT) for …

Background: To evaluate the occurrence of erectile dysfunction at 3 years (3yED) after
prostate brachytherapy (BT) and to predict 3yED after treatment based on patients and …

PURPOSE To review common reported side effects and complications after primary LDR-BT
(monotherapy) and discuss some of the technical aspects that could impact the treatment …